The global flu vaccine market is expected to grow at a CAGR of 5.5% from 2021 to 2030. The growth of the market can be attributed to the increasing number of people suffering from influenza and other respiratory diseases, which is driving the demand for flu vaccines. The increasing awareness about the benefits of vaccination against influenza among healthcare professionals and patients is also driving the growth of this market.
The split influenza vaccine segment accounted for a major share in 2018, due to its high efficacy in preventing seasonal influenza outbreaks. However, it has been observed that there are some limitations associated with this type of vaccine such as low immunogenicity and lack of protection against pandemic strains during an outbreak. This has led to an increase in demand for pandemic influenza vaccines which are more effective than split-influenza vaccines in preventing pandemic outbreaks and have better immunogenicity than split-influenza vaccines during seasonal outbreaks.
North America accounted for a major share in 2018 due to its high adoption rate among adults and children over 3 years old as well as increased awareness about flu vaccination among healthcare professionals and patients across various countries such as Canada, US, Mexico etc, which has led to higher demand for flu vaccines across these regions.
Some Of The Growth Factors Of This Market:
- The flu vaccine is a preventative measure against the flu virus.
- The vaccine is recommended for people who are at high risk of developing complications from the flu, such as children under 5 years old, pregnant women, and people over 65 years old.
- Influenza can be deadly for those with chronic health conditions like asthma or heart disease and can lead to hospitalization or death in otherwise healthy individuals.
- Vaccination rates have been declining in recent years due to misconceptions about the safety of vaccines and their effectiveness in preventing illness; this has led to an increase in cases of influenza across all age groups during the past few seasons, including among children under 5 years old and adults over 65 years old who are at high risk for complications from influenza infection; this has also led to increased hospitalizations and deaths among these populations during recent seasons when vaccination rates were low.
- Vaccination rates have been increasing since 2016-2017 season due to increased awareness about the importance of vaccination.
Industry Growth Insights published a new data on “Flu Vaccine Market”. The research report is titled “Flu Vaccine Market research by Types (Split Influenza Vaccine, Pandemic Influenza Vaccine, Subunit Influenza Vaccine, Quadrivalent Influenza Vaccine), By Applications (For Children (6 months to 3 years), For Adults and Children over 3 years), By Players/Companies Hualan Bio, CCBIO, Aleph Biomedical, SANOFI, Adimmune, ZYAK, SINOVAC, Changsheng Biological, SIOBP, GSK, Aimei Hissen, Tianyuan Bio-pharma(Novartis), Simcere Vaxtec”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Flu Vaccine Market Research Report
By Type
Split Influenza Vaccine, Pandemic Influenza Vaccine, Subunit Influenza Vaccine, Quadrivalent Influenza Vaccine
By Application
For Children (6 months to 3 years), For Adults and Children over 3 years
By Companies
Hualan Bio, CCBIO, Aleph Biomedical, SANOFI, Adimmune, ZYAK, SINOVAC, Changsheng Biological, SIOBP, GSK, Aimei Hissen, Tianyuan Bio-pharma(Novartis), Simcere Vaxtec
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Flu Vaccine Market Report Segments:
The global Flu Vaccine market is segmented on the basis of:
Types
Split Influenza Vaccine, Pandemic Influenza Vaccine, Subunit Influenza Vaccine, Quadrivalent Influenza Vaccine
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
For Children (6 months to 3 years), For Adults and Children over 3 years
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Hualan Bio
- CCBIO
- Aleph Biomedical
- SANOFI
- Adimmune
- ZYAK
- SINOVAC
- Changsheng Biological
- SIOBP
- GSK
- Aimei Hissen
- Tianyuan Bio-pharma(Novartis)
- Simcere Vaxtec
Highlights of The Flu Vaccine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Split Influenza Vaccine
- Pandemic Influenza Vaccine
- Subunit Influenza Vaccine
- Quadrivalent Influenza Vaccine
- By Application:
- For Children (6 months to 3 years)
- For Adults and Children over 3 years
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Flu Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A flu vaccine is a vaccine that helps protect people from the flu. It is made from pieces of the virus and it helps your body learn how to fight off the flu. Flu vaccines are usually given as shots in clinics or hospitals.
Some of the major players in the flu vaccine market are Hualan Bio, CCBIO, Aleph Biomedical, SANOFI, Adimmune, ZYAK, SINOVAC, Changsheng Biological, SIOBP, GSK, Aimei Hissen, Tianyuan Bio-pharma(Novartis), Simcere Vaxtec.
The flu vaccine market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Flu Vaccine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Flu Vaccine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Flu Vaccine Market - Supply Chain
4.5. Global Flu Vaccine Market Forecast
4.5.1. Flu Vaccine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Flu Vaccine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Flu Vaccine Market Absolute $ Opportunity
5. Global Flu Vaccine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Flu Vaccine Market Size and Volume Forecast by Type
5.3.1. Split Influenza Vaccine
5.3.2. Pandemic Influenza Vaccine
5.3.3. Subunit Influenza Vaccine
5.3.4. Quadrivalent Influenza Vaccine
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Flu Vaccine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Flu Vaccine Market Size and Volume Forecast by Application
6.3.1. For Children (6 months to 3 years)
6.3.2. For Adults and Children over 3 years
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Flu Vaccine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Flu Vaccine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Flu Vaccine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Flu Vaccine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Flu Vaccine Demand Share Forecast, 2019-2026
9. North America Flu Vaccine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Flu Vaccine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Flu Vaccine Market Size and Volume Forecast by Application
9.4.1. For Children (6 months to 3 years)
9.4.2. For Adults and Children over 3 years
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Flu Vaccine Market Size and Volume Forecast by Type
9.7.1. Split Influenza Vaccine
9.7.2. Pandemic Influenza Vaccine
9.7.3. Subunit Influenza Vaccine
9.7.4. Quadrivalent Influenza Vaccine
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Flu Vaccine Demand Share Forecast, 2019-2026
10. Latin America Flu Vaccine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Flu Vaccine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Flu Vaccine Market Size and Volume Forecast by Application
10.4.1. For Children (6 months to 3 years)
10.4.2. For Adults and Children over 3 years
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Flu Vaccine Market Size and Volume Forecast by Type
10.7.1. Split Influenza Vaccine
10.7.2. Pandemic Influenza Vaccine
10.7.3. Subunit Influenza Vaccine
10.7.4. Quadrivalent Influenza Vaccine
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Flu Vaccine Demand Share Forecast, 2019-2026
11. Europe Flu Vaccine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Flu Vaccine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Flu Vaccine Market Size and Volume Forecast by Application
11.4.1. For Children (6 months to 3 years)
11.4.2. For Adults and Children over 3 years
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Flu Vaccine Market Size and Volume Forecast by Type
11.7.1. Split Influenza Vaccine
11.7.2. Pandemic Influenza Vaccine
11.7.3. Subunit Influenza Vaccine
11.7.4. Quadrivalent Influenza Vaccine
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Flu Vaccine Demand Share, 2019-2026
12. Asia Pacific Flu Vaccine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Flu Vaccine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Flu Vaccine Market Size and Volume Forecast by Application
12.4.1. For Children (6 months to 3 years)
12.4.2. For Adults and Children over 3 years
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Flu Vaccine Market Size and Volume Forecast by Type
12.7.1. Split Influenza Vaccine
12.7.2. Pandemic Influenza Vaccine
12.7.3. Subunit Influenza Vaccine
12.7.4. Quadrivalent Influenza Vaccine
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Flu Vaccine Demand Share, 2019-2026
13. Middle East & Africa Flu Vaccine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Flu Vaccine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Flu Vaccine Market Size and Volume Forecast by Application
13.4.1. For Children (6 months to 3 years)
13.4.2. For Adults and Children over 3 years
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Flu Vaccine Market Size and Volume Forecast by Type
13.7.1. Split Influenza Vaccine
13.7.2. Pandemic Influenza Vaccine
13.7.3. Subunit Influenza Vaccine
13.7.4. Quadrivalent Influenza Vaccine
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Flu Vaccine Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Flu Vaccine Market: Market Share Analysis
14.2. Flu Vaccine Distributors and Customers
14.3. Flu Vaccine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Hualan Bio
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. CCBIO
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Aleph Biomedical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. SANOFI
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Adimmune
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. ZYAK
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. SINOVAC
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Changsheng Biological
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. SIOBP
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. GSK
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Aimei Hissen
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Tianyuan Bio-pharma(Novartis)
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Simcere Vaxtec
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
